Medicines List

Select category
  • Description

    Esomeprazole-Tchaikapharma contains a medicine called esomeprazole. This belongs to a group of medicines called “proton pump inhibitors”. They work by reducing the amount of acid that your stomach produces.

    Indications

    Esomeprazole-Tchaikapharma is used for the short-term treatment of certain conditions, when you are unable to have treatment by mouth. It is used to treat the following conditions:
    – „Gastroesophageal reflux disease“ (GERD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn;
    – Stomach ulcers caused by medicines called NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). Esomeprazole-Tchaikapharma can also be used to stop stomach ulcers from forming if you are taking NSAIDs;
    – Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 40 mg powder for solution for injection/infusion

    Patient information leaflet

  • Description

    Dexketoprofen-Tchaikapharma solution for injection/infusion is a pain killer from the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).

    Indications

    Dexketoprofen-Tchaikapharma is used to treat acute moderate to severe pain, when taking tablets is not appropriate, such as postoperative pain, renal colic (severe kidney pain) and low back pain.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 50 mg/2 ml solution for injection/infusion

    Patient information leaflet

  • Description

    MoriVid contains the active substance hydroxychloroquine sulfate. It works by reducing inflammation in people with autoimmune diseases (the immune system attacks healthy cells in the body).

    Indications

    Adults:
    – Prevention and treatment of malaria;
    – Treatment of rheumatoid arthritis;
    – Treatment of discoid and systemic lupus erythematosus;
    – Dermatological conditions caused by sunlight.

    Paediatric population (≥ 6 years and ≥ 31 kg):
    – Treatment of juvenile idiopathic arthritis (in combination with other therapies);
    – Treatment of discoid and systemic lupus erythematosus.

    Chloroquine-resistant P. falciparum and increasingly chloroquine-resistant P. vivax are found in many areas, which limits the applicability of hydroxychloroquine in these areas. Official guidelines and local information on the development of resistance to antimalarial agents should be followed.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 200 mg film-coated tablets

    Patient information leaflet

  • Description

    Remifentanil-Tchaikapharma contains a medicine called remifentanil. This belongs to a group of medicines known as opioids.

    Indications

    Remifentanil-Tchaikapharma is used together with other medicines called anaesthetics:
    – to help put you to sleep before an operation;
    – to keep you asleep and stop you feeling pain during an operation;
    – to make you feel sleepy and stop you feeling pain while you receive treatment in an Intensive Care Unit.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 5 mg powder for concentrate for solution for injection/infusion

    Patient information leaflet